What Medicus Pharma Does #newsout #healthcareinnovation #biotechinvesting #medicuspharma

Beyond dermatologic oncology, Medicus is expanding its pipeline with Teverelix, a next-generation therapy targeting advanced prostate cancer and cardiovascular risk, along with additional studies in acute urinary retention. With multiple clinical catalysts ahead and ongoing FDA engagement, the company is positioning itself for continued growth in the biotech sector.

See the full interview here: https://youtu.be/C80cY55NAJA